Mo Jialu, Hu Jiao, Cheng Xianglin
The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China.
The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, China.
Biomed Pharmacother. 2023 May;161:114541. doi: 10.1016/j.biopha.2023.114541. Epub 2023 Mar 22.
High mobility group box 1 (HMGB1) is a ubiquitous and highly conserved non-histone DNA-binding protein with different biological functions according to its subcellular localization. It is widely believed that HMGB1, which is released into the extracellular space, plays a key role in the inflammatory response. In recent years, numerous studies have shown that the development of various neurological diseases such as epilepsy, Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), cerebrovascular disease and traumatic brain injury (TBI) are inextricably linked to inflammation. We will review the mechanisms of HMGB1 and its receptors in nervous system inflammation to provide a basis for further development of new HMGB1-based therapies.
高迁移率族蛋白B1(HMGB1)是一种普遍存在且高度保守的非组蛋白DNA结合蛋白,根据其亚细胞定位具有不同的生物学功能。人们普遍认为,释放到细胞外空间的HMGB1在炎症反应中起关键作用。近年来,大量研究表明,癫痫、阿尔茨海默病(AD)、帕金森病(PD)、肌萎缩侧索硬化症(ALS)、多发性硬化症(MS)、脑血管疾病和创伤性脑损伤(TBI)等各种神经疾病的发展与炎症有着千丝万缕的联系。我们将综述HMGB1及其受体在神经系统炎症中的作用机制,为进一步开发基于HMGB1的新疗法提供依据。